[ad_1]
EEA chief Emer Cooke said Monday the agency was working “around the clock to license the first COVID-19 vaccine.”
Although the EEA’s Committee of Experts should issue its recommendations no later than December 29, “the calendars, of course, remain under review,” he stressed.
“European citizens have told us that they want speedy approval, but more importantly, they want a thorough evaluation of the benefits and risks of the vaccine to be sure of its safety, efficacy and high quality,” Cooke added.
German Health Minister Jens Spahn wrote impatiently on Twitter on Sunday that his country, which had established more than 400 cents of vaccination and used around 10,000 Mass vaccinations of doctors and other doctors requires regulatory approval. Germany could launch a vaccination campaign on Tuesday.
The vaccine, developed by the German company BioNTech and the American pharmaceutical company Pfizer, has already been approved in the United Kingdom, the United States, Canada and elsewhere.
[ad_2]
